Raras
Buscar doenças, sintomas, genes...
Distrofia muscular das cinturas dos membros autossômica recessiva
ORPHA:102015CID-11 · 8C70.41DOENÇA RARA

Forma autossômica recessiva de distrofia muscular de cinturas.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Forma autossômica recessiva de distrofia muscular de cinturas.

Publicações científicas
118 artigos
Último publicado: 2026 Apr 6
Medicamentos
1 registrados
DEFLAZACORT

Tem tratamento?

1 medicamento registrado
Ver detalhes, fases e interações →
DEFLAZACORT
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
90 sintomas
🧠
Neurológico
30 sintomas
🦴
Ossos e articulações
25 sintomas
❤️
Coração
18 sintomas
🫁
Pulmão
12 sintomas
👁️
Olhos
8 sintomas

+ 106 sintomas em outras categorias

Características mais comuns

Oftalmoplegia
Movimento limitado do ombro
Dificuldade para subir escadas
Hipertrofia da coxa
Vesícula cutânea
Amiotrofia do membro inferior
321sintomas
Sem dados (321)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 321 características clínicas mais associadas, ordenadas por frequência.

OftalmoplegiaOphthalmoplegia
Movimento limitado do ombroLimited shoulder movement
Dificuldade para subir escadasDifficulty climbing stairs
Hipertrofia da coxaThigh hypertrophy
Vesícula cutâneaSkin vesicle

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico118PubMed
Últimos 10 anos42publicações
Pico20237 papers
Linha do tempo
2026Hoje · 2026📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

31 genes identificados com associação a esta condição.

Autosomal recessive
TCAPTelethoninDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Muscle assembly regulating factor. Mediates the antiparallel assembly of titin (TTN) molecules at the sarcomeric Z-disk

LOCALIZAÇÃO

Cytoplasm, myofibril, sarcomere

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 25

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
2504.5 TPM
Coração - Ventrículo esquerdo
1812.2 TPM
Coração - Átrio
1252.5 TPM
Cerebelo
14.4 TPM
Cérebro - Hemisfério cerebelar
12.1 TPM
OUTRAS DOENÇAS (3)
autosomal recessive limb-girdle muscular dystrophy type 2Ghypertrophic cardiomyopathy 25familial isolated dilated cardiomyopathy
HGNC:11610UniProt:O15273
FKTNRibitol-5-phosphate transferase FKTNDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the transfer of a ribitol-phosphate from CDP-ribitol to the distal N-acetylgalactosamine of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1) (PubMed:26923585, PubMed:27194101, PubMed:29477842). This constitutes the first step in the formation of the ribitol 5-phosphate tandem repeat which links the phosphorylated O-mannosyl trisaccharide to the ligan

LOCALIZAÇÃO

Golgi apparatus membraneCytoplasmNucleus

VIAS BIOLÓGICAS (1)
Matriglycan biosynthesis on DAG1
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A4

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound intellectual disability, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
21.9 TPM
Nervo tibial
12.9 TPM
Ovário
12.1 TPM
Útero
10.6 TPM
Cérebro - Hemisfério cerebelar
10.4 TPM
OUTRAS DOENÇAS (8)
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4autosomal recessive limb-girdle muscular dystrophy type 2Mmuscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4dilated cardiomyopathy 1X
HGNC:3622UniProt:O75072
POMGNT1Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Participates in O-mannosyl glycosylation by catalyzing the addition of N-acetylglucosamine to O-linked mannose on glycoproteins (PubMed:11709191, PubMed:27493216, PubMed:28512129). Catalyzes the synthesis of the GlcNAc(beta1-2)Man(alpha1-)O-Ser/Thr moiety on alpha-dystroglycan and other O-mannosylated proteins, providing the necessary basis for the addition of further carbohydrate moieties (PubMed:11709191, PubMed:27493216). Is specific for alpha linked terminal mannose and does not have MGAT3,

LOCALIZAÇÃO

Golgi apparatus membrane

VIAS BIOLÓGICAS (3)
DAG1 core M1 glycosylationsDAG1 core M2 glycosylationsMatriglycan biosynthesis on DAG1
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A3

An autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities, cobblestone lissencephaly, and cerebellar and pontine hypoplasia. Patients present severe congenital myopia, congenital glaucoma, pallor of the optic disks, retinal hypoplasia, intellectual disability, hydrocephalus, abnormal electroencephalograms, generalized muscle weakness and myoclonic jerks. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
61.9 TPM
Tireoide
61.2 TPM
Brain Spinal cord cervical c-1
57.1 TPM
Testículo
54.0 TPM
Nervo tibial
52.7 TPM
OUTRAS DOENÇAS (8)
muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3retinitis pigmentosa 76autosomal recessive limb-girdle muscular dystrophy type 2O
HGNC:19139UniProt:Q8WZA1
SGCDDelta-sarcoglycanDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 6

An autosomal recessive degenerative myopathy initially affecting the proximal limb girdle musculature. Muscle from patients shows a complete loss of delta-sarcoglycan as well as of the others components of the sarcoglycan complex.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
26.6 TPM
Aorta
20.2 TPM
Músculo esquelético
15.2 TPM
Esôfago - Junção
14.2 TPM
Coração - Átrio
12.8 TPM
OUTRAS DOENÇAS (4)
autosomal recessive limb-girdle muscular dystrophy type 2Fdilated cardiomyopathy 1Lautosomal recessive limb-girdle muscular dystrophyfamilial isolated dilated cardiomyopathy
HGNC:10807UniProt:Q92629
GMPPBMannose-1-phosphate guanylyltransferase catalytic subunit betaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic subunit of the GMPPA-GMPPB mannose-1-phosphate guanylyltransferase complex (PubMed:33986552). Catalyzes the formation of GDP-mannose, an essential precursor of glycan moieties of glycoproteins and glycolipids (PubMed:33986552). Can catalyze the reverse reaction in vitro (PubMed:33986552). Together with GMPPA regulates GDP-alpha-D-mannose levels (PubMed:33986552)

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Synthesis of GDP-mannose
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A14

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with brain anomalies, eye malformations, and profound intellectual disability. The disorder includes a severe form designated as Walker-Warburg syndrome and a less severe phenotype known as muscle-eye-brain disease. MDDGA14 features include increased muscle tone, microcephaly, cleft palate, feeding difficulties, severe muscle weakness, sensorineural hearing loss, cerebellar hypoplasia, ataxia, and retinal dysfunction.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
56.4 TPM
Tireoide
41.5 TPM
Linfócitos
39.6 TPM
Próstata
37.0 TPM
Glândula salivar
32.5 TPM
OUTRAS DOENÇAS (7)
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14autosomal recessive limb-girdle muscular dystrophy type 2Tmuscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14muscle-eye-brain disease
HGNC:22932UniProt:Q9Y5P6
POMKProtein O-mannose kinaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Protein O-mannose kinase that specifically mediates phosphorylation at the 6-position of an O-mannose of the trisaccharide (N-acetylgalactosamine (GalNAc)-beta-1,3-N-acetylglucosamine (GlcNAc)-beta-1,4-mannose) to generate phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-1,3-N-acetylglucosamine-beta-1,4-(phosphate-6-)mannose). Phosphorylated O-mannosyl trisaccharide is a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like d

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
DAG1 core M3 glycosylations
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A12

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound intellectual disability, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
6.4 TPM
Fibroblastos
5.9 TPM
Cérebro - Hemisfério cerebelar
3.0 TPM
Cerebelo
2.7 TPM
Testículo
2.3 TPM
OUTRAS DOENÇAS (4)
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12limb-girdle muscular dystrophy due to POMK deficiencyobsolete congenital muscular dystrophy with cerebellar involvementmuscular dystrophy-dystroglycanopathy, type A
HGNC:26267UniProt:Q9H5K3
TTNTitinDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Key component in the assembly and functioning of vertebrate striated muscles. By providing connections at the level of individual microfilaments, it contributes to the fine balance of forces between the two halves of the sarcomere. The size and extensibility of the cross-links are the main determinants of sarcomere extensibility properties of muscle. In non-muscle cells, seems to play a role in chromosome condensation and chromosome segregation during mitosis. Might link the lamina network to ch

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Platelet degranulation
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 9, with early respiratory failure

An autosomal dominant myopathy characterized by adulthood onset of weakness in proximal, distal, axial and respiratory muscles. Pelvic girdle weakness, foot drop and neck weakness are the main symptoms at onset, but ultimately the weakness usually involves the proximal compartment of both upper and lower limbs. Additional features include variable degrees of Achilles tendon contractures, spinal rigidity and muscle hypertrophy. Respiratory involvement often leads to requirement for non-invasive ventilation support.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
358.5 TPM
Coração - Ventrículo esquerdo
66.8 TPM
Coração - Átrio
56.9 TPM
Testículo
1.6 TPM
Pulmão
1.0 TPM
OUTRAS DOENÇAS (14)
autosomal recessive limb-girdle muscular dystrophy type 2Jmyopathy, myofibrillar, 9, with early respiratory failureearly-onset myopathy with fatal cardiomyopathydilated cardiomyopathy 1G
HGNC:12403UniProt:Q8WZ42
SGCGGamma-sarcoglycanDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 5

An autosomal recessive degenerative myopathy characterized by rapidly progressive muscle wasting from early childhood with loss of independent ambulation around age 12 years, dystrophic pattern on muscle biopsy, absence of gamma-sarcoglycan and normal dystrophin immunostaining.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Ventrículo esquerdo
59.2 TPM
Músculo esquelético
56.9 TPM
Coração - Átrio
50.8 TPM
Aorta
6.8 TPM
Pulmão
6.7 TPM
OUTRAS DOENÇAS (2)
autosomal recessive limb-girdle muscular dystrophy type 2Cautosomal recessive limb-girdle muscular dystrophy
HGNC:10809UniProt:Q13326
POMT2Protein O-mannosyl-transferase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transfers mannosyl residues to the hydroxyl group of serine or threonine residues. Coexpression of both POMT1 and POMT2 is necessary for enzyme activity, expression of either POMT1 or POMT2 alone is insufficient (PubMed:14699049, PubMed:28512129). Essentially dedicated to O-mannosylation of alpha-DAG1 and few other proteins but not of cadherins and protocaherins (PubMed:28512129)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (5)
Regulation of CDH1 posttranslational processing and trafficking to plasma membraneDAG1 core M1 glycosylationsDAG1 core M3 glycosylationsDAG1 core M2 glycosylationsDefective POMT1 causes MDDGA1, MDDGB1 and MDDGC1
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound intellectual disability, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
59.9 TPM
Pituitária
28.9 TPM
Tireoide
27.7 TPM
Cervix Endocervix
21.2 TPM
Cerebelo
21.2 TPM
OUTRAS DOENÇAS (7)
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2autosomal recessive limb-girdle muscular dystrophy type 2Nmuscle-eye-brain disease
HGNC:19743UniProt:Q9UKY4
LIMS2LIM and senescent cell antigen-like-containing domain protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Adapter protein in a cytoplasmic complex linking beta-integrins to the actin cytoskeleton, bridges the complex to cell surface receptor tyrosine kinases and growth factor receptors. Plays a role in modulating cell spreading and migration

LOCALIZAÇÃO

NucleusCell junction, focal adhesionCell membrane

VIAS BIOLÓGICAS (1)
Cell-extracellular matrix interactions
MECANISMO DE DOENÇA

Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue

An autosomal recessive muscular dystrophy characterized by childhood-onset of muscle weakness progressing to a severe quadriparesis. Additionally, patients have biventricular cardiac dysfunction due to dilated cardiomyopathy, and macroglossia with a small tip resulting in a triangular tongue.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
448.3 TPM
Útero
277.7 TPM
Esôfago - Muscular
273.2 TPM
Esôfago - Junção
266.3 TPM
Artéria tibial
255.2 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
autosomal recessive limb-girdle muscular dystrophy type 2W
HGNC:HGNC:16084UniProt:Q7Z4I7
TRAPPC11Trafficking protein particle complex subunit 11Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in endoplasmic reticulum to Golgi apparatus trafficking at a very early stage

LOCALIZAÇÃO

Golgi apparatusGolgi apparatus, cis-Golgi network

VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 18

A form of limb-girdle muscular dystrophy characterized by proximal muscle weakness with childhood onset, resulting in gait abnormalities and scapular winging. Serum creatine kinase is increased. A subset of patients may show a hyperkinetic movement disorder with chorea, ataxia, or dystonia and global developmental delay.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
33.7 TPM
Cérebro - Hemisfério cerebelar
31.5 TPM
Linfócitos
30.9 TPM
Nervo tibial
29.6 TPM
Cerebelo
29.4 TPM
OUTRAS DOENÇAS (3)
autosomal recessive limb-girdle muscular dystrophy type R18intellectual disability-hyperkinetic movement-truncal ataxia syndrometriple-A syndrome
HGNC:25751UniProt:Q7Z392
DAG1Dystroglycan 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

The dystroglycan complex is involved in a number of signaling events and processes including laminin deposition and extracellular matrix assembly, acetylcholine receptor clustering, sarcolemmal stability, cell survival, peripheral nerve myelination, nodal structure, cell migration, epithelial polarization, and epithelium branching morphogenesis (By similarity). Required for the formation of photoreceptor ribbon synapses, and long-term maintenance of inhibitory synapses in cerebellar Purkinje cel

LOCALIZAÇÃO

Secreted, extracellular spaceSecreted, extracellular space, extracellular matrix, basement membraneSynapseCell membraneCytoplasm, cytoskeletonNucleus, nucleoplasmCell membrane, sarcolemmaPostsynaptic cell membrane

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy limb-girdle C9

An autosomal recessive muscular dystrophy showing onset in early childhood, and associated with intellectual disability without structural brain anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
118.7 TPM
Artéria tibial
71.1 TPM
Aorta
69.5 TPM
Esôfago - Muscular
66.9 TPM
Esôfago - Junção
64.7 TPM
OUTRAS DOENÇAS (5)
autosomal recessive limb-girdle muscular dystrophy type 2Pmuscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9isolated asymptomatic elevation of creatine phosphokinasemuscular dystrophy-dystroglycanopathy, type A
HGNC:2666UniProt:Q14118
POGLUT1Protein O-glucosyltransferase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Dual specificity glycosyltransferase that catalyzes the transfer of glucose and xylose from UDP-glucose and UDP-xylose, respectively, to a serine residue found in the consensus sequence of C-X-S-X-P-C (PubMed:21081508, PubMed:21490058, PubMed:21949356, PubMed:27807076, PubMed:28775322). Specifically targets extracellular EGF repeats of protein such as CRB2, F7, F9 and NOTCH2 (PubMed:21081508, PubMed:21490058, PubMed:21949356, PubMed:27807076, PubMed:28775322). Acts as a positive regulator of Not

LOCALIZAÇÃO

Endoplasmic reticulum lumen

VIAS BIOLÓGICAS (1)
Pre-NOTCH Processing in the Endoplasmic Reticulum
MECANISMO DE DOENÇA

Dowling-Degos disease 4

A form of Dowling-Degos disease, a genodermatosis manifesting with postpubertal reticulate hyperpigmentation that is progressive and disfiguring, and small hyperkeratotic dark brown papules that affect mainly the flexures and great skin folds. Patients usually show no abnormalities of the hair or nails. DDD4 is characterized by prominent involvement of non-flexural skin areas.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
18.8 TPM
Linfócitos
18.3 TPM
Cervix Ectocervix
17.1 TPM
Cervix Endocervix
16.6 TPM
Baço
16.2 TPM
OUTRAS DOENÇAS (3)
autosomal recessive limb-girdle muscular dystrophy type 2R1Dowling-Degos disease 4Dowling-Degos disease
HGNC:22954UniProt:Q8NBL1
SGCBBeta-sarcoglycanDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 4

An autosomal recessive degenerative myopathy characterized by pelvic and shoulder muscle wasting, onset usually in childhood and variable progression rate.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
100.8 TPM
Aorta
89.2 TPM
Artéria tibial
80.8 TPM
Artéria coronária
72.2 TPM
Fibroblastos
69.7 TPM
OUTRAS DOENÇAS (2)
autosomal recessive limb-girdle muscular dystrophy type 2Eautosomal recessive limb-girdle muscular dystrophy
HGNC:10806UniProt:Q16585
CRPPAD-ribitol-5-phosphate cytidylyltransferaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Cytidylyltransferase required for protein O-linked mannosylation (PubMed:22522420, PubMed:22522421, PubMed:26687144, PubMed:26923585, PubMed:27130732, PubMed:27601598). Catalyzes the formation of CDP-ribitol nucleotide sugar from D-ribitol 5-phosphate (PubMed:26687144, PubMed:26923585, PubMed:27130732). CDP-ribitol is a substrate of FKTN during the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carboh

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Matriglycan biosynthesis on DAG1
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A7

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound intellectual disability, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

OUTRAS DOENÇAS (5)
autosomal recessive limb-girdle muscular dystrophy type 2Umuscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7muscle-eye-brain diseasemuscular dystrophy-dystroglycanopathy, type A
HGNC:37276UniProt:A4D126
POMGNT2Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

O-linked mannose beta-1,4-N-acetylglucosaminyltransferase that transfers UDP-N-acetyl-D-glucosamine to the 4-position of the mannose to generate N-acetyl-D-glucosamine-beta-1,4-O-D-mannosylprotein. Involved in the biosynthesis of the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1), which is required for binding laminin G-like domain-containing extracellular prote

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
DAG1 core M3 glycosylations
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A8

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound intellectual disability, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
98.5 TPM
Cerebelo
94.9 TPM
Cérebro - Hemisfério cerebelar
94.0 TPM
Ovário
60.0 TPM
Fallopian Tube
58.8 TPM
OUTRAS DOENÇAS (3)
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8muscular dystrophy-dystroglycanopathy, type A
HGNC:25902UniProt:Q8NAT1
ANO5Anoctamin-5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in plasma membrane repair in a process involving annexins (PubMed:33496727). Does not exhibit calcium-activated chloride channel (CaCC) activity

LOCALIZAÇÃO

Endoplasmic reticulum membraneCell membrane

VIAS BIOLÓGICAS (2)
Induction of Cell-Cell FusionStimuli-sensing channels
MECANISMO DE DOENÇA

Gnathodiaphyseal dysplasia

Rare skeletal syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbone. Patients experience frequent bone fractures caused by trivial accidents in childhood; however the fractures heal normally without bone deformity. The jaw lesions replace the tooth-bearing segments of the maxilla and mandible with fibrous connective tissues, including various amounts of cementum-like calcified mass, sometimes causing facial deformities. Patients also have a propensity for jaw infection and often suffer from purulent osteomyelitis-like symptoms, such as swelling of and pus discharge from the gums, mobility of the teeth, insufficient healing after tooth extraction and exposure of the lesions into the oral cavity.

OUTRAS DOENÇAS (6)
autosomal recessive limb-girdle muscular dystrophy type 2Lgnathodiaphyseal dysplasiaautosomal recessive limb-girdle muscular dystrophyMiyoshi muscular dystrophy 3
HGNC:27337UniProt:Q75V66
POMT1Protein O-mannosyl-transferase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transfers mannosyl residues to the hydroxyl group of serine or threonine residues. Coexpression of both POMT1 and POMT2 is necessary for enzyme activity, expression of either POMT1 or POMT2 alone is insufficient (PubMed:12369018, PubMed:14699049, PubMed:28512129). Essentially dedicated to O-mannosylation of alpha-DAG1 and few other proteins but not of cadherins and protocaherins (PubMed:28512129)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (5)
Regulation of CDH1 posttranslational processing and trafficking to plasma membraneDAG1 core M1 glycosylationsDAG1 core M3 glycosylationsDAG1 core M2 glycosylationsDefective POMT2 causes MDDGA2, MDDGB2 and MDDGC2
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with impaired intellectual development B1

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with intellectual disability and mild structural brain abnormalities.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
73.9 TPM
Cerebelo
65.0 TPM
Cérebro - Hemisfério cerebelar
61.3 TPM
Pituitária
32.9 TPM
Ovário
27.8 TPM
OUTRAS DOENÇAS (8)
autosomal recessive limb-girdle muscular dystrophy type 2Kmuscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1muscle-eye-brain disease
HGNC:9202UniProt:Q9Y6A1
CAPN3Calpain-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Calcium-regulated non-lysosomal thiol-protease. Proteolytically cleaves CTBP1 at 'His-409'. Mediates, with UTP25, the proteasome-independent degradation of p53/TP53 (PubMed:23357851, PubMed:27657329)

LOCALIZAÇÃO

CytoplasmNucleus, nucleolus

VIAS BIOLÓGICAS (1)
Degradation of the extracellular matrix
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 1

An autosomal recessive degenerative myopathy characterized by progressive symmetrical atrophy and weakness of the proximal limb muscles and elevated serum creatine kinase. The symptoms usually begin during the first two decades of life, and the disease gradually worsens, often resulting in loss of walking ability 10 or 20 years after onset.

OUTRAS DOENÇAS (3)
autosomal recessive limb-girdle muscular dystrophy type 2Amuscular dystrophy, limb-girdle, autosomal dominant 4autosomal recessive limb-girdle muscular dystrophy
HGNC:1480UniProt:P20807
DYSFDysferlinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Key calcium ion sensor involved in the Ca(2+)-triggered synaptic vesicle-plasma membrane fusion. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity)

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasmic vesicle membraneCell membraneLate endosome membrane

VIAS BIOLÓGICAS (1)
Smooth Muscle Contraction
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 2

An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
164.1 TPM
Baço
67.3 TPM
Músculo esquelético
44.4 TPM
Pulmão
30.5 TPM
Cólon sigmoide
23.4 TPM
OUTRAS DOENÇAS (6)
autosomal recessive limb-girdle muscular dystrophy type 2Bdistal myopathy with anterior tibial onsetMiyoshi muscular dystrophy 1autosomal recessive limb-girdle muscular dystrophy
HGNC:3097UniProt:O75923
HMGCR3-hydroxy-3-methylglutaryl-coenzyme A reductaseDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the conversion of (3S)-hydroxy-3-methylglutaryl-CoA (HMG-CoA) to mevalonic acid, the rate-limiting step in the synthesis of cholesterol and other isoprenoids, thus plays a critical role in cellular cholesterol homeostasis (PubMed:21357570, PubMed:2991281, PubMed:36745799, PubMed:6995544). HMGCR is the main target of statins, a class of cholesterol-lowering drugs (PubMed:11349148, PubMed:18540668, PubMed:36745799)

LOCALIZAÇÃO

Endoplasmic reticulum membranePeroxisome membrane

VIAS BIOLÓGICAS (1)
EGR2 and SOX10-mediated initiation of Schwann cell myelination
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 28

An autosomal recessive form of limb girdle muscular dystrophy, a group of genetically heterogeneous muscular disorders that share proximal muscle weakness as the major attribute. Most limb girdle muscular dystrophies present with elevated creatinine kinase and myopathic electromyographic features. Disease is usually progressive to a variable degree, ranging from minor disability to complete inability to ambulate, and can involve the large proximal muscles, as well as axial and facial muscles. Different disease forms may exhibit skeletal muscle hypertrophy, kyphoscoliosis, and contractures or involve other muscle groups and manifest with distal weakness, cardiomyopathy, dysphagia, and respiratory difficulties. LGMDR28 is characterized by progressive muscle weakness affecting the proximal and axial muscles of the upper and lower limbs, and highly variable age at onset. Most patients have limited ambulation or become wheelchair-bound within a few decades, and respiratory insufficiency commonly occurs.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
80.4 TPM
Skin Sun Exposed Lower leg
73.8 TPM
Linfócitos
66.2 TPM
Esôfago - Mucosa
63.8 TPM
Vagina
42.9 TPM
OUTRAS DOENÇAS (1)
muscular dystrophy, limb-girdle, autosomal recessive 28
HGNC:5006UniProt:P04035
LAMA2Laminin subunit alpha-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix, basement membrane

VIAS BIOLÓGICAS (8)
MET activates PTK2 signalingDevelopmental Lineage of Pancreatic Ductal CellsAttachment of bacteria to epithelial cellsLaminin interactionsEGR2 and SOX10-mediated initiation of Schwann cell myelination
MECANISMO DE DOENÇA

Merosin-deficient congenital muscular dystrophy 1A

Characterized by difficulty walking, hypotonia, proximal weakness, hyporeflexia, and white matter hypodensity on MRI.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
116.5 TPM
Nervo tibial
92.9 TPM
Fallopian Tube
80.1 TPM
Artéria coronária
63.2 TPM
Fibroblastos
62.6 TPM
OUTRAS DOENÇAS (2)
congenital merosin-deficient muscular dystrophy 1Amuscular dystrophy, limb-girdle, autosomal recessive 23
HGNC:6482UniProt:P24043
POPDC3Popeye domain-containing protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May play a role in the maintenance of heart function mediated, at least in part, through cAMP-binding. May play a role in the regulation of KCNK2/TREK-1-mediated current amplitude (PubMed:31610034)

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 26

An autosomal recessive muscular disorder characterized by adult onset of weakness and atrophy of proximal limb muscles, elevated serum creatine kinase levels, and dystrophic findings on muscle biopsy. There is no cardiac or respiratory involvement.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
82.8 TPM
Fibroblastos
21.8 TPM
Coração - Ventrículo esquerdo
18.0 TPM
Coração - Átrio
14.9 TPM
Brain Frontal Cortex BA9
14.1 TPM
OUTRAS DOENÇAS (1)
muscular dystrophy, limb-girdle, autosomal recessive 26
HGNC:HGNC:17649UniProt:Q9HBV1
POPDC1Popeye domain-containing protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Cell adhesion molecule involved in the establishment and/or maintenance of cell integrity. Involved in the formation and regulation of the tight junction (TJ) paracellular permeability barrier in epithelial cells (PubMed:16188940). Plays a role in VAMP3-mediated vesicular transport and recycling of different receptor molecules through its interaction with VAMP3. Plays a role in the regulation of cell shape and movement by modulating the Rho-family GTPase activity through its interaction with ARH

LOCALIZAÇÃO

Lateral cell membraneCell junction, tight junctionMembraneCell membrane, sarcolemmaMembrane, caveola

MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 25

An autosomal recessive muscular disorder characterized by slowly progressive onset of proximal lower limb weakness in adulthood, syncopal episodes, and markedly increased serum creatine kinase, which can increase further after strenuous exercise.

INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
autosomal recessive limb-girdle muscular dystrophy type 2X
HGNC:1152UniProt:Q8NE79
SGCAAlpha-sarcoglycanDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 3

An autosomal recessive degenerative myopathy characterized by progressive muscle wasting from early childhood with loss of independent ambulation by teenage years. Muscle biopsy shows necrosis, decreased immunostaining for alpha sarcoglycan, and adhalin deficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
227.0 TPM
Aorta
223.0 TPM
Artéria tibial
162.2 TPM
Artéria coronária
146.7 TPM
Esôfago - Junção
94.6 TPM
OUTRAS DOENÇAS (2)
autosomal recessive limb-girdle muscular dystrophyautosomal recessive limb-girdle muscular dystrophy type 2D
HGNC:10805UniProt:Q16586
JAG2Protein jagged-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Putative Notch ligand involved in the mediation of Notch signaling. Involved in limb development (By similarity)

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (7)
Activated NOTCH1 Transmits Signal to the NucleusConstitutive Signaling by NOTCH1 PEST Domain MutantsNOTCH2 Activation and Transmission of Signal to the NucleusNOTCH3 Activation and Transmission of Signal to the NucleusConstitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 27

An autosomal recessive muscular disorder characterized by progressive muscle weakness most prominent in the proximal lower limb and axial muscles, and resulting in walking difficulty or loss of ambulation. Additional more variable features include neck muscle weakness, scoliosis, and joint contractures. Some affected individuals manifest impaired intellectual development or speech delay, cardiomyopathy, and cardiac arrhythmia. Muscle biopsy shows non-specific dystrophic changes.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
56.8 TPM
Skin Not Sun Exposed Suprapubic
51.0 TPM
Skin Sun Exposed Lower leg
44.8 TPM
Mama
31.5 TPM
Próstata
31.1 TPM
OUTRAS DOENÇAS (1)
muscular dystrophy, limb-girdle, autosomal recessive 27
HGNC:HGNC:6189UniProt:Q9Y219
TOR1AIP1Torsin-1A-interacting protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for nuclear membrane integrity. Induces TOR1A and TOR1B ATPase activity and is required for their location on the nuclear membrane. Binds to A- and B-type lamins. Possible role in membrane attachment and assembly of the nuclear lamina

LOCALIZAÇÃO

Nucleus inner membraneNucleus envelopeNucleus

VIAS BIOLÓGICAS (2)
RHOF GTPase cycleRHOD GTPase cycle
MECANISMO DE DOENÇA

Myopathy, autosomal recessive, with rigid spine and distal joint contractures

An autosomal recessive degenerative myopathy characterized by muscle weakness initially involving the proximal lower limbs, followed by distal upper and lower limb muscle weakness and atrophy. Other features include joint contractures, rigid spine, and restricted pulmonary function. Cardiac involvement has been observed in some patients. Disease onset is in the first or second decades of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
39.4 TPM
Esôfago - Muscular
35.9 TPM
Aorta
35.5 TPM
Esôfago - Junção
35.5 TPM
Cólon sigmoide
35.2 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
autosomal recessive limb-girdle muscular dystrophy type 2Y
HGNC:29456UniProt:Q5JTV8
FKRPRibitol 5-phosphate transferase FKRPDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the transfer of a ribitol 5-phosphate from CDP-L-ribitol to the ribitol 5-phosphate previously attached by FKTN/fukutin to the phosphorylated O-mannosyl trisaccharide (N-acetylgalactosamine-beta-3-N-acetylglucosamine-beta-4-(phosphate-6-)mannose), a carbohydrate structure present in alpha-dystroglycan (DAG1) (PubMed:26923585, PubMed:27194101, PubMed:29477842, PubMed:31949166). This constitutes the second step in the formation of the ribose 5-phosphate tandem repeat which links the phos

LOCALIZAÇÃO

Golgi apparatus membraneSecretedCell membrane, sarcolemmaRough endoplasmic reticulumCytoplasm

VIAS BIOLÓGICAS (1)
Matriglycan biosynthesis on DAG1
MECANISMO DE DOENÇA

Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A5

An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound intellectual disability, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
19.7 TPM
Útero
18.0 TPM
Fibroblastos
17.7 TPM
Tireoide
16.6 TPM
Fallopian Tube
16.5 TPM
OUTRAS DOENÇAS (8)
muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5muscular dystrophy-dystroglycanopathy type B5autosomal recessive limb-girdle muscular dystrophy type 2Imuscle-eye-brain disease
HGNC:17997UniProt:Q9H9S5
TRIM32E3 ubiquitin-protein ligase TRIM32Disease-causing germline mutation(s) inTolerante
FUNÇÃO

E3 ubiquitin ligase that plays a role in various biological processes including neural stem cell differentiation, innate immunity, inflammatory resonse and autophagy (PubMed:19349376, PubMed:31123703). Plays a role in virus-triggered induction of IFN-beta and TNF by mediating the ubiquitination of STING1. Mechanistically, targets STING1 for 'Lys-63'-linked ubiquitination which promotes the interaction of STING1 with TBK1 (PubMed:22745133). Regulates bacterial clearance and promotes autophagy in

LOCALIZAÇÃO

CytoplasmMitochondrionEndoplasmic reticulum

VIAS BIOLÓGICAS (2)
Antigen processing: Ubiquitination & Proteasome degradationRegulation of innate immune responses to cytosolic DNA
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 8

An autosomal recessive degenerative myopathy characterized by pelvic girdle, shoulder girdle and quadriceps muscle weakness. Clinical phenotype and severity are highly variable. Disease progression is slow and most patients remain ambulatory into the sixth decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
28.5 TPM
Fibroblastos
24.7 TPM
Cerebelo
21.4 TPM
Útero
20.4 TPM
Cervix Endocervix
19.7 TPM
OUTRAS DOENÇAS (3)
autosomal recessive limb-girdle muscular dystrophy type 2HBardet-Biedl syndrome 11Bardet-Biedl syndrome
HGNC:16380UniProt:Q13049
SNUPNSnurportin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions as an U snRNP-specific nuclear import adapter. Involved in the trimethylguanosine (m3G)-cap-dependent nuclear import of U snRNPs. Binds specifically to the terminal m3G-cap U snRNAs

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
snRNP Assembly
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 29

An autosomal recessive form of limb girdle muscular dystrophy, a group of genetically heterogeneous muscular disorders that share proximal muscle weakness as the major attribute. Most limb girdle muscular dystrophies present with elevated creatinine kinase and myopathic electromyographic features. Disease is usually progressive to a variable degree, ranging from minor disability to complete inability to ambulate, and can involve the large proximal muscles, as well as axial and facial muscles. Different disease forms may exhibit skeletal muscle hypertrophy, kyphoscoliosis, and contractures or involve other muscle groups and manifest with distal weakness, cardiomyopathy, dysphagia, and respiratory difficulties. LGMDR29 is characterized by muscle weakness predominantly affecting the proximal lower limbs, although upper limb involvement also occurs. Additional features include joint contractures, spinal abnormalities, and significant restrictive ventilatory dysfunction. In rare cases, central nervous system involvement has been reported, including cataracts, developmental delay, and brain imaging abnormalities.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
40.0 TPM
Nervo tibial
25.2 TPM
Ovário
24.3 TPM
Fallopian Tube
23.7 TPM
Cervix Endocervix
23.4 TPM
OUTRAS DOENÇAS (1)
muscular dystrophy, limb-girdle, autosomal recessive 29
HGNC:HGNC:14245UniProt:O95149
PLECPlectinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Interlinks intermediate filaments with microtubules and microfilaments and anchors intermediate filaments to desmosomes or hemidesmosomes. Could also bind muscle proteins such as actin to membrane complexes in muscle. May be involved not only in the filaments network, but also in the regulation of their dynamics. Structural component of muscle. Isoform 9 plays a major role in the maintenance of myofiber integrity

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell junction, hemidesmosomeCell projection, podosome

VIAS BIOLÓGICAS (3)
Caspase-mediated cleavage of cytoskeletal proteinsType I hemidesmosome assemblyAssembly of collagen fibrils and other multimeric structures
MECANISMO DE DOENÇA

Epidermolysis bullosa simplex 5C, with pyloric atresia

A form of epidermolysis bullosa, a genodermatosis characterized by recurrent blistering, fragility of the skin and mucosal epithelia, and erosions caused by minor mechanical trauma. EBS5C is an autosomal recessive disorder characterized by severe skin blistering at birth and congenital pyloric atresia. Death usually occurs in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
241.5 TPM
Fibroblastos
212.0 TPM
Músculo esquelético
151.2 TPM
Aorta
144.6 TPM
Artéria tibial
138.0 TPM
OUTRAS DOENÇAS (6)
autosomal recessive limb-girdle muscular dystrophy type 2Qepidermolysis bullosa simplex 5A, Ogna typeepidermolysis bullosa simplex 5C, with pyloric atresiaepidermolysis bullosa simplex 5B, with muscular dystrophy
HGNC:9069UniProt:Q15149

Medicamentos e terapias

DEFLAZACORTPhase 2

Mecanismo: Glucocorticoid receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

734 variantes patogênicas registradas no ClinVar.

🧬 TCAP: NM_003673.4(TCAP):c.152_153insAA (p.Tyr51Ter) ()
🧬 TCAP: GRCh37/hg19 17q12-21.2(chr17:33220181-39572233)x3 ()
🧬 TCAP: NM_003673.4(TCAP):c.165del (p.Gln56fs) ()
🧬 TCAP: NM_003673.4(TCAP):c.110+1_110+5del ()
🧬 TCAP: NM_003673.4(TCAP):c.472C>G (p.Arg158Gly) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 45,440 variantes classificadas pelo ClinVar.

4544
18176
22720
Patogênica (10.0%)
VUS (40.0%)
Benigna (50.0%)
VARIANTES MAIS SIGNIFICATIVAS
TRAPPC11: NM_021942.6(TRAPPC11):c.3075dup (p.Val1026fs) [Pathogenic]
LOC112577517: NM_015602.4(TOR1AIP1):c.373C>T (p.Arg125Ter) [Pathogenic]
LIMS2: NM_001161403.3(LIMS2):c.956_967del (p.Arg319_Lys322del) [Uncertain significance]
CAPN3: NM_000070.3(CAPN3):c.8C>T (p.Thr3Ile) [Uncertain significance]
SGCB: NM_000232.5(SGCB):c.244-21_244-20inv [Uncertain significance]

Vias biológicas (Reactome)

45 vias biológicas associadas aos genes desta condição.

Striated Muscle Contraction Matriglycan biosynthesis on DAG1 Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 DAG1 core M2 glycosylations DAG1 core M1 glycosylations Formation of the dystrophin-glycoprotein complex (DGC) Synthesis of GDP-mannose DAG1 core M3 glycosylations Platelet degranulation Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 Regulation of CDH1 posttranslational processing and trafficking to plasma membrane Cell-extracellular matrix interactions RAB GEFs exchange GTP for GDP on RABs Non-integrin membrane-ECM interactions ECM proteoglycans Regulation of expression of SLITs and ROBOs EGR2 and SOX10-mediated initiation of Schwann cell myelination Pre-NOTCH Processing in the Endoplasmic Reticulum Stimuli-sensing channels Induction of Cell-Cell Fusion Degradation of the extracellular matrix Smooth Muscle Contraction PPARA activates gene expression Activation of gene expression by SREBF (SREBP) Lanosterol biosynthesis Laminin interactions MET activates PTK2 signaling Attachment of bacteria to epithelial cells Developmental Lineage of Pancreatic Ductal Cells Activated NOTCH1 Transmits Signal to the Nucleus Constitutive Signaling by NOTCH1 PEST Domain Mutants Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant Constitutive Signaling by NOTCH1 HD Domain Mutants Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants NOTCH2 Activation and Transmission of Signal to the Nucleus NOTCH3 Activation and Transmission of Signal to the Nucleus RHOD GTPase cycle RHOF GTPase cycle Regulation of innate immune responses to cytosolic DNA Antigen processing: Ubiquitination & Proteasome degradation snRNP Assembly Assembly of collagen fibrils and other multimeric structures Caspase-mediated cleavage of cytoskeletal proteins Type I hemidesmosome assembly

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
Medicamentos catalogadosEnsaios clínicos· 1 medicamento · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Distrofia muscular das cinturas dos membros autossômica recessiva

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
44 papers (10 anos)
#1

Diamond Sign in Calpainopathy.

JAMA neurology2026 Jan 01

This case report describes the appearance of autosomal recessive limb-girdle muscular dystrophy in a 30-year-old man with lower limb weakness, asymmetric atrophy of thigh muscles, and wasting of calf muscles.

#2

Generation of induced pluripotent stem cell lines from three LGMD R1 patients carrying CAPN3 hypomorphic intronic variant c.1746-20C > G.

Stem cell research2025 Sep

Calpainopathy is a progressive autosomal recessive limb girdle muscular dystrophy (LGMD R1) caused by variants in the calpain 3 (CAPN3) gene. We have shown that the hypomorphic intronic mutation c.1746-20C > G, which is common in Latvia (MAF 0.237), causes incorrect splicing of the CAPN3 products that in combination with c.643 T > C variant in trans position leads to the development of LGMD clinical symptoms. Our project aims to generate calpainopathy patient-derived induced pluripotent stem cells (iPSCs) and create a disease model that recapitulates unique CAPN3 variant.

#3

Whole-exome sequencing identifies TRIM72 as a candidate gene for autosomal recessive limb-girdle muscular dystrophy.

Human genomics2025 Aug 13

Limb-girdle muscular dystrophies (LGMDs) constitute a genetically diverse group of disorders characterized by progressive proximal muscle weakness and atrophy. Despite advances in genetic diagnostics, numerous cases remain unresolved due to extensive genetic heterogeneity, emphasizing the necessity for continued identification of novel pathogenic variants. Using whole-exome sequencing (WES) in a Saudi family affected by autosomal recessive LGMD, we identified a novel homozygous frameshift mutation (c.891delT; p.Ala298ArgfsTer64) in the TRIM72 (MG53) gene, which we propose as a strong candidate gene for LGMD. Segregation analysis via Sanger sequencing confirmed that the variant co-segregated precisely with the disease phenotype and was absent in ethnically matched control cohorts. TRIM72 encodes a muscle-specific E3 ubiquitin ligase involved in sarcolemmal membrane repair, critical for maintaining muscle cell integrity. Functional parallels between TRIM72 and the LGMD-associated TRIM32, alongside corroborating evidence from animal models and cellular studies, support the candidacy of TRIM72 in LGMD pathogenesis. Our findings identify TRIM72 as a novel candidate gene implicated in autosomal recessive LGMD, expanding the genetic spectrum of this heterogeneous disease. This discovery underscores the critical roles of TRIM family proteins in muscle pathology and reinforces the value of advanced genetic sequencing methodologies in diagnosing unresolved muscular dystrophy cases.

#4

Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 10 (LGMD,10), Caused by a Novel Homozygous Variant in the TTN Gene.

International medical case reports journal2025

Limb-girdle muscular dystrophy was first introduced in the 1950s as a distinct family of unusual genetic diseases. The prevalence of the disease is about 4-7/1000, with a spectrum of onset at different ages. LGMD has a cluster of symptoms varying in severity and presentation in patients. Limb-girdle muscular dystrophy`s inheritance is unique as it can be autosomal dominant or recessive. We report a young boy with autosomal recessive limb-girdle muscular dystrophy (LGMD), presented with distal muscle weakness in all four limbs for three years and thinning of legs, arms, and thighs. Our gene of focus is TTN, which is associated with muscle elasticity and myogenesis. Our subtype reported is currently associated with a new homozygous TTN variant; thus, we are writing a novel variant mutation causing limb-girdle muscular dystrophy type 10.

#5

[Autosomal recessive limb-girdle muscular dystrophy-10. Case report].

Revista medica del Instituto Mexicano del Seguro Social2025 Jan 03

The autosomal recessive limb-girdle muscular dystrophy-10 (LGMDR10) is a muscular dystrophy caused by pathogenetic variants in the TTN gene encoding the titin protein, which is responsible for muscle flexibility and tension. Its prevalence is unknown. The main clinical manifestations are proximal muscle weakness predominantly in the shoulder girdle and pelvic girdle, mild weakness of distal muscles and muscle atrophy. The objective is to present a case report of autosomal recessive limb-girdle muscular dystrophy-10 in a Mexican patient. 39-year-old male with hypotrophy of the left leg, muscle weakness of the 4 limbs predominantly proximal and asymmetrical, myalgia and nocturnal cramps. Total creatine phosphokinase level was of 819.7 IU/L, nerve conduction velocity and electromyography with left femoral neuropathy of the axonotmesis type and mixed axonal neuropathy with myopathic pattern of upper limbs. The molecular study for muscular dystrophies reported 2 pathogenic variants in compound heterozygous state in the TTN gene: c.107578C>T (p. Gln37860*) and c.104269C>T (p. Gln34767*), respectively. In line with the information available, there are no reported cases of LGMDR10 in Mexico. This is a progressive disease with total loss of ambulation between the fourth and the sixth decade of life, which is why its clinical suspicion is important for a timely diagnosis, an adequate counseling, and preventive measures of complications for a better quality of life. la distrofia muscular de cinturas y extremidades autosómica recesiva 10 (LGMDR10) es una distrofia muscular causada por variantes patogénicas en el gen TTN que codifica la proteína titina, la cual es responsable de la flexibilidad y la tensión muscular. Su prevalencia es desconocida. Las principales manifestaciones clínicas son debilidad muscular proximal de predominio en la cintura escapular y pélvica, leve debilidad de músculos distales y atrofia muscular. El objetivo es presentar un reporte de caso de distrofia muscular de cinturas y extremidades autosómica recesiva 10 en un paciente mexicano. hombre de 39 años con hipotrofia de pierna izquierda, debilidad muscular de las 4 extremidades de predominio proximal y asimétrica, mialgias y calambres nocturnos. La creatinfosfoquinasa total fue de 819.7 UI/L, la velocidad de conducción nerviosa y la electromiografía presentó neuropatía femoral izquierda del tipo axonotmesis y neuropatía mixta axonal con patrón miopático de miembros superiores. El estudio molecular para distrofias musculares reportó 2 variantes patogénicas en estado heterocigoto compuesto en el gen TTN: c.107578C>T (p. Gln37860*) y c.104269C>T (p. Gln34767*), respectivamente. conforme a la información disponible, no existen casos reportados de LGMDR10 en México. Esta es una enfermedad progresiva con pérdida total de la deambulación entre la cuarta y la sexta década de vida, por lo que es importante su sospecha clínica para un diagnóstico oportuno, un asesoramiento adecuado y la prevención de complicaciones para una mejor calidad de vida.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC49 artigos no totalmostrando 41

2026

Diamond Sign in Calpainopathy.

JAMA neurology
2025

Generation of induced pluripotent stem cell lines from three LGMD R1 patients carrying CAPN3 hypomorphic intronic variant c.1746-20C > G.

Stem cell research
2025

Whole-exome sequencing identifies TRIM72 as a candidate gene for autosomal recessive limb-girdle muscular dystrophy.

Human genomics
2025

Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 10 (LGMD,10), Caused by a Novel Homozygous Variant in the TTN Gene.

International medical case reports journal
2025

[Autosomal recessive limb-girdle muscular dystrophy-10. Case report].

Revista medica del Instituto Mexicano del Seguro Social
2025

Variants in CAPN3 Causing Autosomal Dominant Limb-Girdle Muscular Dystrophy Combined With Calpain-3 Deficiency.

Human mutation
2024

Autosomal recessive limb girdle muscular dystrophy-type 5 (LGMDR-5).

BMJ case reports
2023

Novel five nucleotide deletion in dysferlin leads to autosomal recessive limb-girdle muscular dystrophy.

Physiological reports
2023

Patterns of Clinical Progression Among Patients With Autosomal Recessive Limb-Girdle Muscular Dystrophy: A Systematic Review.

Journal of clinical neuromuscular disease
2023

Single-centre experience with autosomal recessive limb-girdle muscular dystrophy: case series and literature review.

Arquivos de neuro-psiquiatria
2023

Disease modeling and gene correction of LGMDR21 iPSCs elucidates the role of POGLUT1 in skeletal muscle maintenance, regeneration, and the satellite cell niche.

Molecular therapy. Nucleic acids
2023

Autosomal Recessive Limb-Girdle Muscular Dystrophy-3: A Case Report of a Patient with Autism Spectrum Disorder.

Genes
2023

How a paternal uniparental isodisomy of chromosome 17 leads to autosomal recessive limb-girdle muscular dystrophy R3.

Neuromuscular disorders : NMD
2023

Large Region of Homozygous (ROH) Identified in Indian Patients with Autosomal Recessive Limb-Girdle Muscular Dystrophy with p.Thr182Pro Variant in SGCB Gene.

Human mutation
2022

Homozygous Inversion on Chromosome 13 Involving SGCG Detected by Short Read Whole Genome Sequencing in a Patient Suffering from Limb-Girdle Muscular Dystrophy.

Genes
2022

A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B.

International journal of molecular sciences
2022

A novel splice site variant in the POPDC3 causes autosomal recessive limb-girdle muscular dystrophy type 26.

Clinical genetics
2022

Progression to Loss of Ambulation Among Patients with Autosomal Recessive Limb-girdle Muscular Dystrophy: A Systematic Review.

Journal of neuromuscular diseases
2021

Compound heterozygous c.598_612del and c.1746-20C > G CAPN3 genotype cause autosomal recessive limb-girdle muscular dystrophy-1: a case report.

BMC musculoskeletal disorders
2021

Muscle magnetic resonance imaging in patients with LAMA2-related muscular dystrophy.

Neuromuscular disorders : NMD
2022

A recurrent rare intronic variant in CAPN3 alters mRNA splicing and causes autosomal recessive limb-girdle muscular dystrophy-1 in three Pakistani pedigrees.

American journal of medical genetics. Part A
2021

Natural history and genetic study of LAMA2-related muscular dystrophy in a large Chinese cohort.

Orphanet journal of rare diseases
2021

Clinical Determinants of Disease Progression in Patients With Beta-Sarcoglycan Gene Mutations.

Frontiers in neurology
2021

[A Japanese family with POMT2-related limb girdle muscular dystrophy].

Rinsho shinkeigaku = Clinical neurology
2020

Two Japanese LGMDR25 patients with a biallelic recurrent nonsense variant of BVES.

Neuromuscular disorders : NMD
2020

Novel CAPN3 variant associated with an autosomal dominant calpainopathy.

Neuropathology and applied neurobiology
2019

Homozygous missense variant in the TTN gene causing autosomal recessive limb-girdle muscular dystrophy type 10.

BMC medical genetics
2019

POPDC3 Gene Variants Associate with a New Form of Limb Girdle Muscular Dystrophy.

Annals of neurology
2019

Clinicogenetic lessons from 370 patients with autosomal recessive limb-girdle muscular dystrophy.

Clinical genetics
2019

Autosomal recessive limb-girdle and Miyoshi muscular dystrophies in the Netherlands: The clinical and molecular spectrum of 244 patients.

Clinical genetics
2019

Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients.

Orphanet journal of rare diseases
2018

[Coincidence of hereditary motor and sensory neuropathy type 1A and limb girdle muscular dystrophy type 2A].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2018

Limb girdle muscular dystrophy 2G in a religious minority of Bulgarian Muslims homozygous for the c.75G>A, p.Trp25X mutation.

Neuromuscular disorders : NMD
2018

Calpain 3 and CaMKIIβ signaling are required to induce HSP70 necessary for adaptive muscle growth after atrophy.

Human molecular genetics
2017

Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy.

Journal of cell science
2016

LGMD2D syndrome: the importance of clinical and molecular genetics in patient and family management. Case Report.

Neuro endocrinology letters
2016

A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss.

EMBO molecular medicine
2016

TRIM32 ubiquitin E3 ligase, one enzyme for several pathologies: From muscular dystrophy to tumours.

The international journal of biochemistry & cell biology
2015

Limb-girdle muscular dystrophy type 2A in Brazilian children.

Arquivos de neuro-psiquiatria
2015

Limb Girdle Muscular Dystrophy (LGMD): Case Report.

Journal of clinical and diagnostic research : JCDR
2015

Diagnostic clues and manifesting carriers in fukutin-related protein (FKRP) limb-girdle muscular dystrophy.

Journal of the neurological sciences
Ver todos os 49 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Distrofia muscular das cinturas dos membros autossômica recessiva.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Distrofia muscular das cinturas dos membros autossômica recessiva

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Diamond Sign in Calpainopathy.
    JAMA neurology· 2026· PMID 40952715mais citado
  2. Generation of induced pluripotent stem cell lines from three LGMD R1 patients carrying CAPN3 hypomorphic intronic variant c.1746-20C > G.
    Stem cell research· 2025· PMID 40834588mais citado
  3. Whole-exome sequencing identifies TRIM72 as a candidate gene for autosomal recessive limb-girdle muscular dystrophy.
    Human genomics· 2025· PMID 40804694mais citado
  4. Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 10 (LGMD,10), Caused by a Novel Homozygous Variant in the TTN Gene.
    International medical case reports journal· 2025· PMID 40487049mais citado
  5. [Autosomal recessive limb-girdle muscular dystrophy-10. Case report].
    Revista medica del Instituto Mexicano del Seguro Social· 2025· PMID 40267405mais citado
  6. Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study.
    Muscle Nerve· 2026· PMID 41943552recente
  7. Expanded clinical and genetic characterization of autosomal recessive HMGCR-related muscular dystrophy.
    J Neuromuscul Dis· 2026· PMID 41904993recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:102015(Orphanet)
  2. MONDO:0015152(MONDO)
  3. GARD:19825(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q27429766(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Distrofia muscular das cinturas dos membros autossômica recessiva
Compêndio · Raras BR

Distrofia muscular das cinturas dos membros autossômica recessiva

ORPHA:102015 · MONDO:0015152
CID-11
Medicamentos
1 registrados
MedGen
UMLS
C2931907
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades